Write in a clean editor, then format for Biosafety and Health in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Biosafety and Health is a peer-reviewed journal published by Elsevier, covering SARS-CoV-2 and COVID-19 Research, Viral gastroenteritis research and epidemiology, SARS-CoV-2 detection and testing.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Biosafety and Health 12 (2023) 45–58.
Formats any DOI in Biosafety and Health style. No sign-up. |
| Publishes research in | SARS-CoV-2 and COVID-19 Research Viral gastroenteritis research and epidemiology SARS-CoV-2 detection and testing COVID-19 Clinical Research Studies Viral Infections and Vectors |
| ISSN | 2590-0536 |
| Citation impact (2-yr) | 3.28 |
| h-index | 29 |
| i10-index | 119 |
| Total citations | 5,037 |
| Article processing charge | $2,500 |
| Open access | Yes |
| Top institutions publishing here | National Institute for Viral Disease Control and Prevention |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Antimicrobial resistance leads to failure of clinical antimicrobial therapy, and has raised urgent global public health concern. Humans can acquire antimicrobial resistance from drugs through the food chain or the environment (contaminated water, air, soil, or manure). While antimicrobials have been regular supplements in animal feed that maintain health and improve productivity of livestock, their…
As of March 12th Italy has the largest number of SARS-CoV-2 cases in Europe as well as outside China. The infections, first limited in Northern Italy, have eventually spread to all other regions. When controlling an emerging outbreak of an infectious disease it is essential to know the key epidemiological parameters, such as the basic…
Coronavirus disease 2019 (COVID-19) pandemic has spread in 220 countries/regions to wreak havoc to human beings around the world. At present, the second wave of COVID-19 has begun in many European countries. The complete control of COVID-19 is very urgent. Although China quickly brought the virus under control, there have been eight sporadic outbreaks in…
A novel bat-origin coronavirus emerged in Wuhan, China in December 2019 and continues to spread across China and the world. At the time of writing, a massive global response has been implemented to control the disease as it spreads from person to person. Yet the high-risk human-wildlife interactions and interfaces that led to the emergence…
The wide use and abuse of antibiotics could make antimicrobial resistance (AMR) an increasingly serious issue that threatens global health and imposes an enormous burden on society and the economy. To avoid the crisis of AMR, we have to fundamentally change our approach. Artificial intelligence (AI) represents a new paradigm to combat AMR. Thus, various…
